Comparison

RTC-5

Item no. CS-0087637-10mg
Manufacturer ChemScene
Amount 10mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1423077-49-9
Similar products 1423077-49-9
Available
Alternative Names
TRC-382
CAS
1423077-49-9
Purity
>98%
MWt
510.96
Formula
C24H22ClF3N2O3S
Solubility
DMSO : 15 mg/mL (29.36 mM; Need ultrasonic)
Clinical Information
No Development Reported
Pathway
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Target
EGFR; EGFR
Biological Activity
RTC-5 (TRC-382) is an optimized phenothiazine with anti-cancer potency. RTC-5 demonstrates efficacy against a xenograft model of an EGFR driven cancer, its effects is attributed to concomitant negative regulation of PI3K-AKT and RAS-ERK signaling[1]. IC50 & Target: IC50: EGFR[1] In Vitro: RTC-5 (0-40 uM; 48 hours) inhibits H1650 lung adenocarcinoma cell growth with an GI50 of 12.6uM[1].
RTC-5 (20-40 uM; 24 hours) negatively regulates PI3K-AKT and RAS-ERK pathways by decreasing phospho-AKT and phospho-ERK levels expression[1].
Research Area
Cancer

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close